Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

KAN-PROSPECT: a Kolmogorov-Arnold Networks-integrated framework for predicting the effects and adverse reactions of natural products via transfer learning.

Scientific reports·2026

Same author

GRIP-Lung: Generative Model of Response to Drug-Induced Perturbation in Lung Cancer.

International journal of molecular sciences·2026

Same author

Vegetation restoration increases soil aggregate stability and aggregate-associated black carbon content in a karst rocky desertification area in southwestern Guangxi.

Frontiers in plant science·2026

Same author

Mechanisms of organotropism in breast cancer and predicting metastasis to distant organs using deep learning.

Discover oncology·2025

Same author

Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.

International journal of molecular sciences·2025

Same author

Impact of Hashimoto's thyroiditis on the tumor microenvironment in papillary thyroid cancer: insights from single-cell analysis.

Frontiers in endocrinology·2024

Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026

Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026

Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026

Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026

Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026

Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 25, 2025

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Exploring Precise Medication Strategies for OSCC Based on Single-Cell Transcriptome Analysis from a Dynamic

Qingkang Meng¹, Feng Wu², Guoqi Li¹

¹Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.

|October 14, 2022

Summary

This summary is machine-generated.

This study introduces a novel pseudo-time score to dynamically assess oral squamous cell carcinoma (OSCC) heterogeneity. This score predicts patient prognosis and guides personalized drug strategies for better treatment outcomes.

Keywords:

cell trajectory inference drug discovery oral squamous cell carcinoma precise medication single-cell RNA-Seq

More Related Videos

Multiplexed Single Cell mRNA Sequencing Analysis of Mouse Embryonic Cells

Multiplexed Single Cell mRNA Sequencing Analysis of Mouse Embryonic Cells

Published on: January 7, 2020

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

Related Experiment Videos

Last Updated: Aug 25, 2025

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Multiplexed Single Cell mRNA Sequencing Analysis of Mouse Embryonic Cells

Multiplexed Single Cell mRNA Sequencing Analysis of Mouse Embryonic Cells

Published on: January 7, 2020

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

Area of Science:

Oncology
Genomics
Bioinformatics

Background:

Most oral squamous cell carcinoma (OSCC) patients are diagnosed at advanced stages, facing poor prognoses due to complex tumor heterogeneity.
Current single-cell studies offer static views, neglecting the dynamic nature of cancer development.

Purpose of the Study:

To dynamically dissect OSCC heterogeneity and evolutionary processes using single-cell RNA sequencing (scRNA-Seq).
To establish a link between cancer heterogeneity and patient prognosis for clinical application.
To pioneer a patient pseudo-time score for dynamic heterogeneity assessment and treatment guidance.

Main Methods:

Combined static and dynamic analysis of scRNA-Seq data.
Dissected OSCC heterogeneity and evolutionary trajectory.
Developed and validated a patient pseudo-time score correlating with prognosis.

Main Results:

Revealed associations between OSCC heterogeneity and patient prognosis.
Demonstrated that the pseudo-time score reflects tumor status and predicts survival.
Identified candidate drugs and proposed precision medication strategies for OSCC treatment and prevention.

Conclusions:

The pseudo-time score offers a dynamic measure of OSCC heterogeneity, closely linked to prognostic status.
This score can guide timely adjustments in medication strategies, improving patient outcomes.
Pioneered precision medicine approaches for OSCC by identifying targeted drugs and treatment strategies.